The MD Anderson Cancer Care Series: Pediatric Oncology. Edited by Ka Wah Chan and R. Beverly Raney, Jr. New York: Springer-Verlag, 2005. 304 pages. Softcover. ISBN 0-387-24470-0.
Innovative research conducted over the past four decades has resulted in important advances in the clinical management of cancer in children and adolescents. Today, the 5-year survival rate for all children with cancer is 70%.
The pediatric oncology faculty members at MD Anderson Cancer Center, who in 2004 saw 500 new pediatric patients, are recognized as leaders in developing improved diagnostic, therapeutic, and supportive-care protocols specifically for children and adolescents. This work is valuable, because when managing pediatric patients with leukemia, lymphoma, tumors of the brain, soft tissue, and bone, and other malignancies, clinicians must take into consideration the unique pathology of these diseases in this population. MD Anderson has introduced several new anticancer agents and supportive-care strategies that are now used throughout the country in the care of young people with cancer.
This book describes the policies currently used at MD Anderson in the clinical management of pediatric patients with cancer. It presents the guidelines practiced at the institution in the multimodality treatment of the most common childhood cancers and describes the institution’s extraordinary Adolescent and Young Adult Program, a national model for cancer care in these select age groups. As in previous volumes of the MD Anderson Cancer Care Series, each chapter ends with a list of suggested readings and key practice points. The latter provides an at-a-glance summary of the important principles of pediatric oncology clinical practice.
This thorough, practical volume is an essential guide for oncologists, pediatricians, surgeons, and other health care providers who treat children and adolescents with cancer.